id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-282339-a1ln2v2p	Pinto, Daniel	The role of breast FNA during and post‐ COVID‐19 pandemic: a fast and safe alternative to needle core biopsy	2020-07-23		.txt	text/plain	1908	143	54	We would invite the reader to challenge their preconceptions of breast FNABs: not only have ancillary tests have been shown to be viable on both smears and cell blocks but, in 2019, the Yokohama System for Reporting Breast Fine‐Needle Aspiration Biopsy Cytopathology was developed and validated, enabling an accurate and reproducible categorization of breast lesions, significantly reducing the need for follow‐up CNBs. Thus, the major limitations of breast FNABs have been addressed. (21, 22 ) When compared to fine-needle aspiration biopsies (FNAB), CNBs have some advantages, such as enabling the assessment of suspicious microcalcifications detected by mammography, distinguishing in situ from invasive lesions and providing material for performing theranostic biomarkers, enabling personalized therapy. One could also argue that, given the minimal invasive nature of the FNAB procedure, the risk of infection from a asymptomatic COVID-19 patient should be low, and even lower when compared to a CNB procedure which may involve more personnel and time to perform.	./cache/cord-282339-a1ln2v2p.txt	./txt/cord-282339-a1ln2v2p.txt